Forest Laboratories, Inc. Commences Consent Solicitations To Eliminate Existing Registration Rights Obligations On Certain Of Its Senior Notes

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) today announced that, subject to the close of the pending acquisition (the “Acquisition”) of Forest by Actavis plc (NYSE: ACT), Actavis is offering to guarantee certain of Forest’s outstanding debt securities in exchange for the elimination of the existing registration rights obligations with respect to those outstanding debt securities.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC